-
Posted by
Two Blokes Apr 17 -
Filed in
Stock
-
3 views
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
